← Open Payments lookup

SARAH SOBOTKA: Open Payments

NPI 1063897213 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 32 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $542 · 2025 $686

Food & beverage: $686
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.9$208
Astellas Pharma US Inc8$187
Biogen, Inc.5$85
MAYNE PHARMA COMMERCIAL LLC4$82
Exeltis, USA Inc.3$44
CooperSurgical, Inc.1$37
Octapharma USA, Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$17

Products named: MYFEMBREE, Veozah, ZURZUVAE, SLYND, Paragard T 380A, FIBRYGA, Lynkuet.

Industry payments across NE — which companies pay providers there.